Oncogenetics

Eur Rev Med Pharmacol Sci 2022; 26 (24): 9393-9408
DOI: 10.26355/eurrev_202212_30690

Multiple targets of Nrf 2 inhibitor; trigonelline in combating urethane-induced lung cancer by caspase-executioner apoptosis, cGMP and limitation of cyclin D1 and Bcl2

M.A. Hamzawy, A.M. Abo-Youssef, M.N. Malak, M.M. Khalaf
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (20): 7580-7593
DOI: 10.26355/eurrev_202210_30033

An in silico analysis of the impact of POLE mutations on cladribine docking

L. Loganathan, A. Al-Haidose, A. Ganesh Kumar, L.B. Sujatha, F.H. Carlus, A. Alharbi, S. Alhyassat, K. Muthusamy, S.J. Carlus, A.M. Abdallah
Free PDF Download

Eur Rev Med Pharmacol Sci 2012; 16 (11): 1582-1587

Bioinformatics analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes

X. Wu, W. Zang, S. Cui, M. Wang
Free PDF Download

Eur Rev Med Pharmacol Sci 2012; 16 (10): 1355-1361

Identifying crosstalk of mTOR signaling pathway of lobular breast carcinomas

G. Sun, M.H. Shan, B.L. Ma, Z.L. Geng, A. Alibiyati, H. Zhong, J. Wang, G.H. Ren, H.T. Li, C. Dong
Free PDF Download